Enhabit, Inc., is a Dallas, Texas-based provider of home health and hospice services. The company operates 255 home health and 110 hospice locations in 34 states with a concentration in Texas, Alabama, Florida, Georgia, Oklahoma and Mississippi. Enhabit is the fourth-largest provider of home health services in the United States and is a leading provider of hospice services. The company was formed in 2022 when Encompass Health spun off its home health and hospice business.
| trading_symbol | registrant_name | time | price | change | percentage_change |
|---|---|---|---|---|---|
| EHAB | Enhabit, Inc. | 2025-12-02 08:00:02 | 9.5 | -0.2 | -2.11 |
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EHAB | 0001803737 | Enhabit, Inc. | US29332G1022 | 549300RFQ78SLDFSHF49 | 472409192 | NYSE | 8082 | Services-Home Health Care Services | 1231 | DE | 6688 N. CENTRAL EXPRESSWAY, SUITE 1300 | DALLAS | TX | 75206 | UNITED STATES | US | 4696216419 | 6688 N. CENTRAL EXPRESSWAY, SUITE 1300, DALLAS, TX, 75206 | 6688 N. CENTRAL EXPRESSWAY, SUITE 1300, DALLAS, TX, 75206 | Encompass Health Home Health Holdings, Inc. | Healthcare | 2022 | Barbara Jacobsmeyer | 10,800 | http://ehab.com | 440,400,000 | 50,589,768 | 50,607,075 | Enhabit, Inc., is a Dallas, Texas-based provider of home health and hospice services. The company operates 255 home health and 110 hospice locations in 34 states with a concentration in Texas, Alabama, Florida, Georgia, Oklahoma and Mississippi. Enhabit is the fourth-largest provider of home health services in the United States and is a leading provider of hospice services. The company was formed in 2022 when Encompass Health spun off its home health and hospice business. | 2025-11-27 17:58:01 |
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
|---|---|---|---|---|---|---|
| 2024 | 440,400,000 | -130,300,000 | -22.8316 | 50,637,417 | 481,635 | 0.9603 |
| 2023 | 570,700,000 | -529,300,000 | -48.1182 | 50,155,782 | 66,454 | 0.1327 |
| 2022 | 1,100,000,000 | 1,100,000,000 | 100 | 50,089,328 | 50,089,328 | 100 |
| Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Julie D. Jolley | Executive Vice President | 2024 | 390,000 | 0 | 333,586 | 68,250 | 2,588 | 794,424 |
| Dylan C. Black | Secretary, General Counsel | 2024 | 350,002 | 0 | 278,028 | 61,250 | 0 | 689,280 |
| Barbara A. Jacobsmeyer | Chief Executive Officer, President | 2024 | 850,000 | 0 | 2,065,211 | 223,125 | 2,588 | 3,140,924 |
| Ryan T. Solomon | Chief Financial Officer | 2024 | 19,231 | 300,000 | 1,000,003 | 7,292 | 0 | 1,326,526 |
| Tanya R. Marion | Chief Human Resources Officer | 2024 | 350,002 | 0 | 289,681 | 61,250 | 2,588 | 703,520 |
| Fiscal Year | Employee Count |
|---|---|
| 2024 | 10,700 |
| 2023 | 10,800 |
| 2022 | 11,000 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 1,034,800,000 | 1,046,300,000 | 1,071,100,000 |
| Cost Of Revenue | 530,800,000 | 535,600,000 | 525,600,000 |
| Gross Profit | — | — | — |
| Research And Development Expenses | — | — | — |
| General And Administrative Expenses | 425,900,000 | 441,600,000 | 414,900,000 |
| Operating Expenses | — | — | — |
| Operating Income | -115,100,000 | -47,600,000 | -11,400,000 |
| Net Income | -156,200,000 | -80,500,000 | -40,400,000 |
| Earnings Per Share Basic | -3.11 | -1.61 | -0.81 |
| Earnings Per Share Diluted | -3.11 | -1.61 | -0.81 |
| Weighted Average Shares Outstanding Basic | 50,200,000 | 49,900,000 | 49,700,000 |
| Weighted Average Shares Outstanding Diluted | 50,200,000 | 49,900,000 | 49,700,000 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Cash And Cash Equivalents | 28,400,000 | 27,400,000 | 22,900,000 |
| Marketable Securities Current | — | — | — |
| Accounts Receivable | 149,700,000 | 164,700,000 | 150,500,000 |
| Inventories | — | — | — |
| Non Trade Receivables | — | 3,000,000 | 11,400,000 |
| Other Assets Current | 5,500,000 | 8,400,000 | 7,500,000 |
| Total Assets Current | 192,700,000 | 210,100,000 | 211,800,000 |
| Marketable Securities Non Current | — | — | — |
| Property Plant And Equipment | — | — | — |
| Other Assets Non Current | 4,700,000 | 5,300,000 | 5,200,000 |
| Total Assets Non Current | 1,033,300,000 | 1,223,500,000 | 1,315,000,000 |
| Total Assets | 1,226,000,000 | 1,433,600,000 | 1,526,800,000 |
| Accounts Payable | 6,700,000 | 7,600,000 | 3,800,000 |
| Deferred Revenue | — | — | — |
| Short Term Debt | 22,800,000 | 22,500,000 | 23,100,000 |
| Other Liabilities Current | 36,400,000 | 40,700,000 | 40,700,000 |
| Total Liabilities Current | 126,200,000 | 137,700,000 | 132,900,000 |
| Long Term Debt | 492,600,000 | 530,100,000 | 560,000,000 |
| Other Liabilities Non Current | 0 | 1,300,000 | 1,900,000 |
| Total Liabilities Non Current | 545,900,000 | 594,200,000 | 618,600,000 |
| Total Liabilities | 672,100,000 | 731,900,000 | 751,500,000 |
| Common Stock | 500,000 | 500,000 | 500,000 |
| Retained Earnings | 98,300,000 | 254,500,000 | 335,000,000 |
| Accumulated Other Comprehensive Income | -200,000 | -500,000 | -700,000 |
| Total Shareholders Equity | 523,500,000 | 669,700,000 | 741,700,000 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Depreciation And Amortization | 31,500,000 | 30,900,000 | 33,000,000 |
| Share Based Compensation Expense | 11,700,000 | 8,900,000 | 9,200,000 |
| Other Non Cash Income Expense | 600,000 | 400,000 | -100,000 |
| Change In Accounts Receivable | -15,500,000 | 14,600,000 | -21,600,000 |
| Change In Inventories | — | — | — |
| Change In Non Trade Receivables | — | — | — |
| Change In Other Assets | — | — | — |
| Change In Accounts Payable | -1,000,000 | 3,800,000 | 200,000 |
| Change In Other Liabilities | -10,200,000 | 400,000 | 7,500,000 |
| Cash From Operating Activities | 51,200,000 | 48,400,000 | 80,100,000 |
| Purchases Of Marketable Securities | — | — | — |
| Sales Of Marketable Securities | — | — | — |
| Acquisition Of Property Plant And Equipment | 3,800,000 | 3,500,000 | 7,100,000 |
| Acquisition Of Business | 0 | 2,800,000 | 36,300,000 |
| Other Investing Activities | -1,400,000 | -1,000,000 | -1,100,000 |
| Cash From Investing Activities | -2,400,000 | -5,300,000 | -42,300,000 |
| Tax Withholding For Share Based Compensation | — | — | — |
| Payments Of Dividends | — | — | — |
| Issuance Of Common Stock | — | — | — |
| Repurchase Of Common Stock | — | — | — |
| Issuance Of Long Term Debt | 0 | 0 | 190,000,000 |
| Repayment Of Long Term Debt | 20,000,000 | 20,000,000 | 10,000,000 |
| Other Financing Activities | -1,000,000 | -700,000 | -1,200,000 |
| Cash From Financing Activities | -48,300,000 | -40,500,000 | -18,600,000 |
| Change In Cash | 500,000 | 2,600,000 | 19,200,000 |
| Cash At End Of Period | 28,400,000 | 27,400,000 | 22,900,000 |
| Income Taxes Paid | 800,000 | — | 11,900,000 |
| Interest Paid | 42,700,000 | 40,600,000 | 13,100,000 |
| Fiscal Year | 2024 | 2023 |
|---|---|---|
| Earnings Per Share | -3.11 | -1.61 |
| Price To Earnings Ratio | -2.5113 | -6.4286 |
| Earnings Growth Rate | 93.1677 | 98.7654 |
| Price Earnings To Growth Ratio | -0.027 | -0.0651 |
| Book Value Per Share | 11.0339 | 14.0621 |
| Price To Book Ratio | 0.7078 | 0.736 |
| Ebitda | -81,000,000 | -6,600,000 |
| Enterprise Value | 879,062,000 | 1,041,665,000 |
| Dividend Yield | — | — |
| Dividend Payout Ratio | — | — |
| Debt To Equity Ratio | 0.9845 | 0.8251 |
| Capital Expenditures | — | — |
| Free Cash Flow | — | — |
| Return On Equity | -0.2984 | -0.1202 |
| One Year Beta | 0.9989 | 0.9983 |
| Three Year Beta | 0.788 | 0.715 |
| Five Year Beta | 0.788 | 0.715 |
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
|---|---|---|---|---|---|
| Bolton Jeffrey | Director | 2025-10-10 | 4,688 | A | 133,241 |
| ELSON CHARLES M | Director | 2025-10-10 | 2,344 | A | 77,417 |
| Ohlendorf Mark W | Director | 2025-10-10 | 2,344 | A | 42,646 |
| Rodgers Stephan | Director | 2025-10-10 | 2,344 | A | 18,117 |
| Rush Gregory S | Director | 2025-10-10 | 3,125 | A | 76,043 |
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
|---|---|---|---|---|
| JPMORGAN CHASE & CO | 2025-09-30 | 2,337,502 | 291,823 | 8.01 |
| CIBC Private Wealth Group LLC | 2025-09-30 | 40 | 5 | 8 |
| Sunbelt Securities, Inc. | 2025-09-30 | 16 | 2 | 8 |
| Caitong International Asset Management Co., Ltd | 2025-09-30 | 889 | 111 | 8.009 |
| Advisory Services Network, LLC | 2025-09-30 | 127,055 | 15,862 | 8.01 |
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
|---|---|---|---|---|---|---|
| RYDEX SERIES FUNDS | 2025-09-30 | Class C | RYCMX | 70 | 560.7 | 0.0084 |
| RYDEX SERIES FUNDS | 2025-09-30 | Class A | RYAKX | 70 | 560.7 | 0.0084 |
| RYDEX SERIES FUNDS | 2025-09-30 | Class H | RYMKX | 70 | 560.7 | 0.0084 |
| RYDEX SERIES FUNDS | 2025-09-30 | Class H | RYRHX | 116 | 929.16 | 0.0075 |
| RYDEX SERIES FUNDS | 2025-09-30 | Class C | RYROX | 116 | 929.16 | 0.0075 |